Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updates were applied to the page, introducing new revision tags (v3.5.4) and prior version (v3.5.3) with associated dates. They reflect maintenance/version control rather than substantive changes to the trial details.SummaryDifference0.4%

- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe ClinicalTrials.gov page’s revision/version identifier was updated from v3.5.2 to v3.5.3, indicating a site-side software/version change with no substantive changes to the study details.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check115 days agoChange DetectedAdded Revision: v3.4.2 and removed the previous funding/operating status notice (Revision: v3.4.1).SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.